The Rutgers Cancer Institute of New Jersey announced it has begun a clinical trial that will examine whether an anti-malaria drug doctors are administering as an off-label use to treat the coronavirus is more effective when taken with an antibiotic. Clinical trials take year to complete. But Rutgers, a nationally recognized comprehensive cancer center, has the in-house expertise to move faster, said Rutgers Cancer Institute Director Steven K. Libutti, who is overseeing the trial. To read the full article.
Recent Posts
- Abdominal Fat Can Impact Brain Health and Cognition in High Alzheimer’s Risk Individuals.
- Peptides for Weight Loss: What to Know, According to Experts.
- New NJACTS Publication
- Nine Dimensions of Authentic Community Engagement
- Rutgers study finds patients with schizophrenia are less likely to be rehospitalized when given antipsychotic injections.